Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

Vaccine
Volume 40, Issue 9 Pages 1191-1384 (23 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/9

 

Research article Open access
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, … Todd C. Zion
Pages 1253-1260